Clinical trials
Prognosis clinical trials
Below are recruiting prognosis clinical trials, each written for real people, not researchers. We’re tracking 239 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07078890Recruiting
Bone graft with implant removal for better reimplant success
This study tests whether adding a bone graft at the same time a failed dental implant is removed helps the new implant placed later in the same spot heal better. It may be a good option if you need a failed implant replaced and want to improve bone support for the new one.
Wuhan, HubeiAges 18–90 - NCT03211975Recruiting
Understanding the Course of Heart Valve Infections
This study follows patients diagnosed with infectious endocarditis (a serious infection of the heart valve) to better understand how the condition progresses and what factors affect outcomes. Researchers will use imaging tests and surgical information to track your health over time.
Amiens, PicardieAges 18 years+ - NCT03268668Recruiting
Study brain clot makeup and blood markers after stroke
This study looks at the composition of a stroke blood clot and compares it with blood test results to understand treatment response, stroke cause, and prognosis. It may help doctors better predict outcomes and improve care after ischemic stroke.
BordeauxAges 18 years+ - NCT05848310Recruiting
Blood test before surgery to predict biliary atresia outcome
This study looks at a specific pre-surgery blood marker called FGF19 (and related liver blood tests) in children with biliary atresia. The goal is to see whether the blood results before surgery can help predict how well children recover after surgery.
Shanghai, Shanghai MunicipalityAges Any age - NCT06655233Recruiting
Exploring gut bacteria in pancreatic cancer tumors
This trial studies bacteria found inside pancreatic tumors to see if they can help diagnose or predict the course of the disease. You may be eligible if you have a suspected pancreatic cancer and need a special biopsy (EUS-FNB).
Hunan, HunanAges 18–80 - NCT06856993Recruiting
Study of early risk signs after sudden death
This study looks at tiny particles in the blood (exosomes) to see if they can help predict how patients do after a sudden collapse. The goal is to better understand who might recover and how to improve their care.
Nanjing, JiangsuAges 18 years+ - NCT07376681Enrolling by invitation
Fertility in young breast cancer patients
This study looks at fertility, cancer outcomes, and children's health in women diagnosed with breast cancer at age 40 or younger. It aims to help you understand how breast cancer and its treatment may affect your ability to have children and your long-term health.
Taizhou, ZhejiangAges 18–40 - NCT06703944Enrolling by invitation
Predicting neuroblastoma spread risk
This trial uses a risk model to help detect if neuroblastoma has spread to the bone or bone marrow in newly diagnosed patients. It aims to improve how doctors identify metastasis without needing extra special tests.
Shanghai, Shanghai MunicipalityAges Any age - NCT07782632Recruiting
Imaging scans to predict immunotherapy response in liver cancer
This study looks at how doctors can use imaging scans to predict how well immunotherapy will work for people with liver cancer that cannot be removed by surgery. Participants must have already received immunotherapy and have had baseline scans.
Hefei, AnhuiAges 18–75 - NCT06484153RecruitingPhase 2
New drug combo for advanced colorectal cancer
This trial tests a new combination of three drugs—fruquintinib (a targeted therapy), pirfenidone (an anti-fibrotic drug), and an immunotherapy (anti-PD-1)—for people with advanced colorectal cancer that has not responded to at least two prior treatments. The goal is to see if this triple therapy can shrink tumors more effectively than current options.
Wuhan, HubeiAges 18–75 - NCT07136701Recruiting
Pancreatic neuroendocrine tumor risk factors and prognosis
This study looks at how pancreatic neuroendocrine tumors behave differently in younger versus older people. It aims to find better ways to predict outcomes and guide treatment.
Jinan, ShandongAges 18–85 - NCT06666881Recruiting
Exercise training for head and neck cancer patients
This trial studies if exercise training can improve outcomes for people with head and neck squamous cell cancer who need chemotherapy and radiation. It uses body scans to see if muscle changes from exercise are linked to better prognosis.
New Taipei CityAges 20–80 - NCT07381803RecruitingPhase 3
Fexofenadine for heart attack recovery
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
Hangzhou, ZhejiangAges 18 years+ - NCT05614050Recruiting
Study of outcomes after a heart stent procedure in China
This study follows people with coronary heart disease who get PCI (a procedure to open clogged heart arteries, often with a stent) and looks at their prognosis afterward. It may help researchers understand what affects recovery and outcomes after the procedure.
Wuhan, HubeiAges 18–80 - NCT03806972Recruiting
Study outcomes after emergency heart failure admission
This study follows people admitted to the emergency department for acute heart failure to understand their short- and long-term outcomes. It may help doctors predict who needs more support and improve follow-up after discharge.
Monastir, Monastir GovernorateAges 18–80 - NCT07066813Recruiting
Lung cancer with air pockets: staging and treatment
This study looks at lung cancers that have air-filled spaces inside them. It explores how the stage of the cancer affects treatment outcomes. If you have this type of lung cancer and have had surgery, this trial may help doctors learn more about your condition.
Changsha, HunanAges Any age - NCT06756009Recruiting
Eye scans to check liver disease and transplant outlook
This study uses advanced eye scans to see if your eyes can give clues about your chronic liver disease and how well you might do after a liver transplant. If you have advanced liver disease or cirrhosis, and are maybe waiting for a transplant, you may join.
Guangzhou, GuangdongAges 18 years+ - NCT06515587Recruiting
Lewis antigen test for pancreatic cancer prognosis
This study looks at how a special blood test (Lewis antigen) combined with a standard CA19-9 test might help predict the outlook for people with pancreatic cancer. You will give a small extra blood sample and have routine follow-up tests.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06568679Recruiting
Improving detection and treatment of early-onset colorectal cancer
This study aims to find better ways to detect and treat colorectal cancer in younger adults (ages 18–49). It includes people with both early-stage and advanced cancer.
Amsterdam, North HollandAges 18–49 - NCT05950087Recruiting
Blood tests after chemoradiotherapy for cervical cancer prognosis
This study looks at blood markers—tiny DNA from the blood (cfDNA) and minimal residual disease (MRD)—to better predict outcomes after standard chemoradiotherapy for locally advanced cervical cancer. It may help doctors identify who is more likely to do well and who may need closer follow-up or additional treatment planning.
Guiyang, GuizhouAges 18–75 - NCT06076226Recruiting
Donor telomere length and leukemia transplant outcomes
This trial looks at whether the length of telomeres (the protective caps at the ends of chromosomes) in donor blood cells affects recovery for people with acute leukemia who receive a stem cell transplant. It aims to see if a simple donor blood test can predict how well the transplant works.
Hangzhou, ZhejiangAges 5–90 - NCT03492528Recruiting
Heart care study for people starting cancer treatment
This study follows adults who are referred to a heart (cardio-oncology) specialist before starting cancer treatment. It may help doctors better understand heart outcomes in people with cancer and improve how heart risks are managed early.
MarseilleAges 18 years+ - NCT02060565Recruiting
Test noninvasive scans to diagnose chronic liver disease
This study looks at how well noninvasive tests (tests that don’t require surgery, like scans and blood-based measurements) can diagnose chronic liver disease in people with certain liver conditions. It may help doctors choose better, less invasive ways to identify the type and stage of liver problems.
PessacAges 18 years+ - NCT04581122Recruiting
Tests how lymph node surgery choices affect lung nodule outcomes
This study looks at whether different lymph node removal methods during lung surgery change outcomes for certain abnormal lung spots. It focuses on ground-glass nodules that stay the same after treatment-free observation and have a mostly solid portion on CT.
ShanghaiAges 18–75
Hear when a new Prognosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prognosis?
- Yes. Clin2 currently lists 239 recruiting prognosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prognosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prognosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.